Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

LAVAL, QC, April 11 /PRNewswire-FirstCall/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news media to the Annual and Special Meeting of Shareholders to be held on Tuesday, April 15, 2008, at 10:00 A.M., in the Maxwell-Cummings Auditorium of the Michal and Renata Hornstein Pavilion of the Montreal Museum of Fine Arts, 1379 Sherbrooke Street West, Montreal, Quebec.

Immediately following the meeting, Dr. Bellini and members of senior management will be available for questions from the news media.

SOURCE NEUROCHEM INC.

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.